| Members |
targetComponentId |
| astrocytom |
Astrocytoma |
| Astrovirus |
Family Astroviridae (organism) |
| utsatt för risk på grund av avsaknad av kolmonoxiddetektor i bostaden |
Inadequate carbon monoxide detection equipment in residence |
| utsatt för risk på grund av avsaknad av brandsläckare i bostaden |
Inadequate fire extinguishing equipment in residence (finding) |
| utsatt för risk på grund av avsaknad av brandvarnare i bostaden |
Inadequate smoke detection equipment in residence (finding) |
| riskerar oplanerad graviditet |
At increased risk for unplanned pregnancy (finding) |
| ataxi samtidig med och orsakad av cerebrotendinös xantomatos |
Ataxia due to cerebrotendinous xanthomatosis |
| ataxi orsakad av förvärvad vitaminbrist |
Acquired ataxia due to vitamin deficiency |
| Atherosclerosis of other specified arteries |
Atherosclerosis |
| atonisk epilepsi |
Epilepsy |
| Atorvastatin calcium 10mg tablet |
Atorvastatin (as atorvastatin calcium) 10 mg oral tablet |
| Atorvastatin calcium 20mg tablet |
Atorvastatin (as atorvastatin calcium) 20 mg oral tablet |
| Atorvastatin calcium 40mg tablet |
Atorvastatin (as atorvastatin calcium) 40 mg oral tablet |
| atosiban 7,5 mg/ml, infusionskoncentrat, flaska 5 ml |
Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Atovaquone+proguanil hydrochloride |
Product containing atovaquone and proguanil (medicinal product) |
| atrakuriumbesylat 100 mg/ 10 ml, lösning |
Atracurium besilate 10 mg/mL solution for injection |
| förmaksmyxom med lentiginos |
Carney complex (disorder) |
| Atrophic age-related macular degeneration |
Nonexudative age-related macular degeneration (disorder) |
| Atrophic glossitis |
Atrophy of tongue papillae |
| atropin 2,1 mg + pralidoxim 600 mg, lösning, en autoinjektor |
Product containing only atropine and pralidoxime in parenteral dose form (medicinal product form) |
| Atropine sulfate + edrophonium chloride 0.14mg/10mg injection |
Product containing only atropine and edrophonium (medicinal product) |
| atropinsulfat 0,031 %, ögondroppar |
Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug) |
| atropinsulfat 0,062 %, ögondroppar |
Atropine sulfate 620 microgram/mL eye solution |
| atropinsulfat 0,1 %, ögondroppar |
Atropine sulfate 1 mg/mL eye solution |
| atropinsulfat 0,25 %, ögondroppar |
Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| atropinsulfat 140 mikrogram + edrofoniumklorid 10 mg, injektionsvätska, lösning, flaska |
Product containing only atropine and edrophonium (medicinal product) |
| atropinsulfat 500 mikrogram/5 ml, oral lösning |
Atropine only product in oral dose form |
| atropinsulfat 500 mikrogram/5 ml, sockerfri lösning |
Atropine only product in oral dose form |
| fastsättning av lambåtransplantat till extremitet |
Reconstruction of extremity using flap |
| fastsättning av lambå på hand |
Reconstruction of hand using flap (procedure) |
| fastsättning av ljumsklambå till hand |
Reconstruction of hand using distant groin flap (procedure) |
| Attachment of pedicle flap graft |
Reconstruction using skin flap |
| fastsättning av stjälkad lambå |
Reconstruction using skin flap |
| Attend allowance exam NOS: [DS4] or [DS1500] |
Attendance allowance medical |
| Attend allowance exam NOS: [DS4] or [DS1500] |
Attendance allowance medical |
| Attention to prosthesis of aorta NOS |
Attention to prosthesis of aorta |
| atypisk absensepilepsi |
Atypical absence seizure |
| atypiskt antipsykotiskt medel |
Anti-psychotic agent (substance) |
| Auditory function |
Hearing |
| Augmentation of alveolar ridge NEC |
Augmentation of alveolar ridge |
| moster eller faster till patienten |
Aunt |
| Aurantimonas altamirensis |
Aureimonas altamirensis (organism) |
| Aureobacterium |
Microbacterium |
| Aureobacterium saperdae |
Microbacterium saperdae (organism) |
| Aureobacterium species |
Microbacterium |
| aurikulär lambå |
Flap (substance) |
| syndrom med aurikulookulär anomali och läppspalt |
Auricular abnormality, cleft lip, ocular abnormality syndrome |
| syndrom med autism och portvinsfläck i ansiktet |
Sturge-Weber syndrome |
| autistisk störning |
Pervasive developmental disorder (disorder) |
| Autistic disorder |
Pervasive developmental disorder (disorder) |
| autogen transplantation av vaskulariserad benvävnad |
Autogenous vascularised bone |
| Autograft |
Autograft |
| Autograft to organ NOC |
Autogenous transplantation |
| Autoimplant |
Autoimplant |
| autointoxikation |
Intestinal dysbiosis |
| Automobile mechanic |
Motor vehicle mechanic |
| Automotive battery fluid causing toxic effect |
Toxic effect of sulfuric acid |
| Autoreplacement of organ NOC |
Autogenous transplantation |
| autosomalt dominant muskeldystrofi typ 1B i skulder-bäckengördel |
Autosomal dominant Emery-Dreifuss muscular dystrophy (disorder) |
| autosomalt dominant muskeldystrofi i skulder-bäckengördel, typ 1C |
Rippling muscle disease (disorder) |
| autosomalt dominant okulokutan albinism |
Piebaldism (disorder) |
| autosomalt recessiv muskeldystrofi i skulder-bäckengördel, typ 2R |
Desmin-related myofibrillar myopathy (disorder) |
| adenovirus grupp 2, fågel |
Turkey adenovirus A (organism) |
| adenovirus grupp 3, fågel |
Duck adenovirus 1 (organism) |
| Avian astrovirus |
Genus Avastrovirus (organism) |
| Avian paramyxovirus |
Genus Avulavirus (organism) |
| Avian reovirus |
Avian orthoreovirus (organism) |
| avobenzon 2 % / ekamsul 2 % / oktokrylen 10 %, kräm för lokalt bruk |
Product containing only avobenzone and ecamsule and octocrilene (medicinal product) |
| avobenzon 2 % / ekamsul 2 % / oktokrylen 10 % / titandioxid 2 %, kräm för lokalt bruk |
Product containing only avobenzone and ecamsule and octocrilene and titanium dioxide (medicinal product) |
| avobenzon 2 % / ekamsul 3 % / oktokrylen 10 %, kräm för lokalt bruk |
Product containing only avobenzone and ecamsule and octocrilene (medicinal product) |
| avobenzon 2 % / ekamsul 3 % / oktokrylen 10 % / titandioxid 5 %, kräm för lokalt bruk |
Product containing only avobenzone and ecamsule and octocrilene and titanium dioxide (medicinal product) |
| avokado, livsmedel |
Avocado (substance) |
| avskärande av nervus alveolaris inferior vid osteotomi |
Avulsion of inferior alveolar nerve due to osteotomy (disorder) |
| Avulsion of tooth |
Complete avulsion of tooth (disorder) |
| axillär kärlsäkrad lambå |
Axial pattern flap |
| bukens axillarlinje |
Anterior axillary line of abdomen |
| azatadinmaleat + pseudoefedrinsulfat 1 mg/120 mg, tablett med modifierad frisättning |
Azatadine and pseudoephedrine only product in oral dose form |
| azatadinmaleat 1 mg + pseudoefedrinsulfat 120 mg, depåtablett |
Azatadine and pseudoephedrine only product in oral dose form |
| azitromycin 1 %, lösning för oftalmiskt bruk |
Azithromycin 10 mg/mL eye drops |
| Azithromycin 100mg/5mL oral suspension |
Product containing precisely azithromycin 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Azithromycin 250mg tablet |
Product containing precisely azithromycin 250 milligram/1 each conventional release oral tablet (clinical drug) |
| azitromycin 2 g/60 ml, mikrosfärer till oral suspension |
Product containing precisely azithromycin 33.3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Azithromycin 600mg tablet |
Product containing precisely azithromycin 600 milligram/1 each conventional release oral tablet (clinical drug) |
| azitromycindihydrat 100 mg/5 ml, suspension |
Product containing precisely azithromycin 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Azithromycin dihydrate 250mg capsule |
Product containing precisely azithromycin 250 milligram/1 each conventional release oral tablet (clinical drug) |
| astreonam 75 mg, pulver til lösning för nebulisator |
Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| B-lymfoblastleukemi/lymfom, kategori |
B lymphoblastic leukaemia lymphoma |
| B-lymfoblastleukemi/lymfom, ingen ICD-O-subtyp |
B lymphoblastic leukaemia lymphoma |
| Babesia equi |
Theileria equi (organism) |
| antikropp mot Babesia equi |
Theileria equi antibody |
| Baboon type C oncovirus |
Baboon endogenous virus (organism) |
| barnet extremt prematurt, 28-32 veckor |
Baby premature 28-32 weeks (finding) |
| Baby extremely premature 28-32 weeks |
Baby premature 28-32 weeks (finding) |
| prematurt barn, 37 veckor |
Term infant 37 weeks (finding) |
| Baby premature 37 weeks |
Term infant 37 weeks (finding) |
| Baby premature 37 weeks |
Term infant 37 weeks (finding) |
| prematurt barn, 38 veckor |
Term infant 38 weeks |
| Baby premature 38 weeks |
Term infant 38 weeks |
| Baby premature 38 weeks |
Term infant 38 weeks |
| Baby premature 39 weeks |
Term infant 39 weeks (finding) |
| Baby premature 39 weeks |
Term infant 39 weeks (finding) |
FHIR